Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Pentose begins phase I/II trials of PEN-203

April 16, 1998

Beta-lactamase inhibitors available for licensing from RCT

April 16, 1998

Antiviral drugs advisory committee will discuss Priftin NDA

April 15, 1998

Erythromycins for Gram-positive and other infections in development at HMR

April 14, 1998

Famciclovir shows better activity than valaciclovir in preclinical trials for the treatment of HSV

April 14, 1998

IntraBiotics develops novel cyclic peptide antimicrobials

April 8, 1998

Novel antimicrobial compounds for Clostridium infections described by Abbott

April 3, 1998

Broad-spectrum antibacterial agents synthesized by Daiichi

April 2, 1998

Antibacterial quinolone carboxylic acids prepared at Bayer

April 1, 1998

Pharmacokinetic study of biapenem indicates safety in various patient groups

April 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.